WHO ICTRP trial
The Heart Institute of Japan Candesartan Randomized trial for Evaluation in…
JPRN-UMIN000000790 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000000790 |
|---|---|
| Public title | The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease |
| Scientific title | The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease - HIJ-CREATE |
| Primary sponsor | HIJC Study group |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Coronary artery disease |
| Interventions | Candesartan-based therapy without any angiotensin-converting enzyme inhibitors Non-ARB based standard therapy |
| Registration date | Jul 11, 2007 |
| Target size | 2030 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: